Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: Preliminary case-series and feasibility

Addiction

Volumn 105, Issue 9, 2010, Pages 1669-1676

  Fishman, Marc J ^a,b   Winstanley, Erin L ^c,d   Curran, Erin ^a,b   Garrett, Shannon ^b   Subramaniam, Geetha ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mountain Manor Treatment Center   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d LINDNER CENTER OF HOPE   (United States)

Author keywords

Adolescents; extended release naltrexone; medication assisted treatment; naltrexone; opioid dependence; pharmacotherapy; young adults

Indexed keywords

BUPRENORPHINE; NALTREXONE; NARCOTIC ANTAGONIST;

ADOLESCENT; ADULT; ARTICLE; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; OPIATE ADDICTION; PARENT; PATIENT SATISFACTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BUPRENORPHINE; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PARENTS; PATIENT SATISFACTION; RECURRENCE; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE DETECTION; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955378331     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03015.x     Document Type: Article

References (22)

1. Johnston L. D., O'Malley P. M., Bachman J. G., Schulenberg J. E. Monitoring the Future National Survey Results on Drug Use, 1975-2005: Volume I, Secondary School Students (NIH Publication no. 06-5883). Bethesda, MD : National Institute on Drug Abuse 2006.
2. Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Applied Studies (OAS). The NSDUH Report: Patterns and Trends in Nonmedical Prescription Pain Reliever Use: 2002 to 2005. Rockville, MD : SAMHSA OAS 2007.
3. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-32, DHHS Publication no. SMA 07-4293). Rockville, MD : Substance Abuse and Mental Health Services Administration 2007.
4. Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Applied Studies (OAS). Admissions aged 12-17 by primary substance of abuse: TEDS 1995-2005, Table 5.1a. 2006. Available at: http://wwwdasis.samhsa.gov/ teds05/TEDSAd2k5Tbl5.1a.htm (accessed 19 September 2007).
5. Morral A. R., McCaffrey D. F., Ridgeway G. Effectiveness of community-based treatment for substance-abusing adolescents: 12-month outcomes of youths entering Phoenix Academy or alternative probation dispositions. Psychol Addict Behav 2004 18 : 257 268.
6. Marsch L. A., Bickel W. K., Badger G. J., Stothart M. E., Quesnel K. J., Stanger C. et al. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry 2005 62 : 1157 1164.
7. Clemmey P., Payne L., Fishman M. Clinical charactertistics and treatment outcomes of adolescent heroin users. J Psychoactive Drugs 2004 36 : 85 94.
8. Fiellin D. Treatment of adolescent opioid dependence: no quick fix. JAMA 2008 300 : 2057 2059.
9. Woody G. E., Poole S. A., Subramaniam G., Dugosh K., Bogenschutz M., Abbott P. et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 2008 300 : 2003 2020.
10. Johansson B. A., Berglund M., Lindgren A. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Addiction 2006 101 : 491 503.
11. Cornish J. W., Metzger D., Woody G. E., Wilson D., McLellan A. T., Vandergrift B. et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 1997 14 : 529 534.
12. Washton A. M., Pottash A. C., Gold M. S. Naltrexone in addicted business executives and physicians. J Clin Psychiatry 1984 45 : 39 41.
13. Krupitsky E. M., Zvartau E. E., Masalov D. V., Tsoi M. V., Burakov A. M., Egorova V. Y. et al. Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat 2004 26 : 258 294.
14. Krupitsky E. M., Zvartau E. E., Masalov D. V., Tsoy M. V., Burakov A. M., Egorova V. Y. et al. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat 2006 31 : 319 328.
15. Comer S. D., Sullivan M. A., Yu E., Rothenberg J. L., Kleber H. D., Kampman K. et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence. Arch Gen Psychiatry 2006 63 : 210 218.
16. Hulse G., Morris N., Arnold-Reed D., Tait R. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. Arch Gen Psychiatry 2009 66 : 1108 1115.
17. Fishman M., Clemmey P., Adger H. Mountain Manor Treatment Center: residential adolescent addictions treatment program. In : Stevens S., Morral A., editors. Adolescent Substance Abuse Treatment in the United States. New York : Haworth Press 2003, p. 135 154.
18. Bigelow G. E., Preston K. L., Schimittner J., O'Brien C. P., Dong Q., Gastfriend D. R. 2006). A randomized, single-dose, opioid challenge study of extended-release naltrexone in opioid-using adults. Poster (and podium) presentation at the 45th Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, FL; 3-7 December 2006.
19. Fishman M. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone. Addiction 2008 103 : 1399 1401.
20. Cornish J. W., Henson D., Levine S., Volpicelli J., Inturrisi C., Yoburn B. et al. Naltrexone maintenance: effect on morphine sensitivity in normal volunteers. Am J Addict 1993 2 : 34 8.
21. Sullivan M. A., Comer S. D., Nunes E. V. Pharmacology and clinical use of naltrexone. In : Strain E. C., Stitzer M. L., editors. The Treatment of Opioid Dependence. Baltimore, MD : The Johns Hopkins University Press 2006, p. 295 322.
22. Hulse G., Tait R. J. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users. Addict Biol 2003 8 : 337 342.